News
Czech Republic, Romania lead in CEM17’s best poster presentations
Innovative research from Czech Republic and Romania dominated the best poster presentations at the 17th Central European Meeting (CEM17) with studies by Czech urologists collecting four of the six best poster prizes. In the Young Urologist Competition, Hungarian D.P....
CEM17: Young urologists show best work in well-attended contest
Eight young urologists from across Central Europe showed their best work and innovative insights in various topics ranging from penile cancer, new training models to donor nephrectomy, during the Young Urologists Competition held in the second day of the 17th...
CEM17 takes up onco-urology issues in Plzen
Onco-urological experts examined current issues during the first plenary session of the EAU 17th Central European Meeting (CEM17) held in conjunction with the 63rd Annual Conference of the Czech Urological Society (CUS) which opened today in Plzen, Czech Republic. “We...
PCa17: What to expect in future prostate cancer management
The number of promising biomarkers at different molecular levels are increasing, accompanied by numerous testing in the market, but cancer experts say independent and prospective validation is crucial to help the medical community eventually provide optimal care to cancer...
PCa17: Interactive, compact meeting opens in Vienna
Challenges in diagnosis, staging and patient selection were among the issues taken up in the first plenary session of the EAU Update on Prostate Cancer (PCa17) opened in Vienna today. With more than 300 participants including faculty and exhibitors,...
EMUC17: Improving reporting systems, defining selection criteria in PCa diagnosis
Despite gains in imaging technology and molecular research, pathologists engage in prostate cancer diagnosis are faced with dissimilar reporting systems and the lack of efficient selection criteria that are needed to further improve the accuracy of diagnosing prostate cancer...
EMUC17: Using biomarkers in decision-making for RCC treatment
Renal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as biomarkers and other molecular techniques to distinguish aggressive diseases. With new research outcomes, physicians are hopeful that diagnosis and therapy...
ESU introduces new urolithiasis e-course in collaboration with EULIS
The EAU Education Online course Introduction to Upper Urinary Tract Endoscopy for Stones is the latest installment to a series of highly-informative e-courses designed to equip junior urologists and to refresh the more experienced with the latest in ureteroscopic stone...
Discovery Award for Israeli bio-chip testing technology
An Israeli testing technology that rapidly identifies bacterial infection in hours instead of days has won the Discovery Award, a financing grant from the United Kingdom that will enable the team to further test and expand the use of...
ESAU17: “Approaching male fertility problems as a sign of more general disease”
For two days in November, Malmö will be welcoming experts on andrology from all over the world for the 10th Meeting of the EAU Section of Andrological Urology. This meeting is the first of its kind in several years, organised...
EAU, EUGA issue consensus statement on implant use in treating POP and SUI
The European Urology Association (EAU) and the European Urogynaecological Association (EUGA) have issued a consensus review statement on the use of implanted materials in managing Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI) in which both organisations have...
Call for proposals to use biological samples collected as part of the MAGNOLIA study
The EAU Research Foundation is inviting applications to utilise the biological samples (Tissue – FFPE and fresh frozen, Blood – Serum and Urine) that were collected as part of the MAGNOLIA study which has now completed. The MAGNOLIA study...